Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by China Nepstar Chain Drugstore Ltd.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
15-12B | Document | Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001144204-16-118936 (34 Act) Size: KB |
Aug-15-2016 | 161829867 |
25-NSE | Document | Acc-no: 0000876661-16-001172 (34 Act) Size: KB | Aug-04-2016 | 161806602 |
SC 13D/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000903423-16-001189 (34 Act) Size: KB |
Aug-04-2016 | 161805980 |
S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001144204-16-116275 (33 Act) Size: KB |
Aug-03-2016 | 161804561 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001144204-16-116273 (34 Act) Size: KB |
Aug-03-2016 | 161804532 |
SC 13E3/A | Document | Amendment to Schedule filed to report going private transactions Acc-no: 0001144204-16-116218 (34 Act) Size: KB |
Aug-03-2016 | 161803941 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001144204-16-115146 (34 Act) Size: KB |
Jul-29-2016 | 161791910 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001144204-16-109222 (34 Act) Size: KB |
Jun-22-2016 | 161725582 |
SC 13E3/A | Document | Amendment to Schedule filed to report going private transactions Acc-no: 0001144204-16-109218 (34 Act) Size: KB |
Jun-22-2016 | 161725560 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001144204-16-105664 (34 Act) Size: KB |
May-31-2016 | 161683824 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001144204-16-100622 ( Act) Size: KB |
May-11-2016 | |
SC 13E3/A | Document | Amendment to Schedule filed to report going private transactions Acc-no: 0001144204-16-100620 (34 Act) Size: KB |
May-11-2016 | 161637704 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001144204-16-098779 ( Act) Size: KB |
May-04-2016 | |
SC 13E3/A | Document | Amendment to Schedule filed to report going private transactions Acc-no: 0001144204-16-098777 (34 Act) Size: KB |
May-04-2016 | 161617439 |
UPLOAD | Document | Acc-no: 0000000000-16-074702 ( Act) Size: KB | May-03-2016 | |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001144204-16-097367 ( Act) Size: KB |
Apr-29-2016 | |
SC 13E3/A | Document | Amendment to Schedule filed to report going private transactions Acc-no: 0001144204-16-097364 (34 Act) Size: KB |
Apr-29-2016 | 161602415 |
UPLOAD | Document | Acc-no: 0000000000-16-073804 ( Act) Size: KB | Apr-26-2016 | |
20-F | Document | Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0001144204-16-096179 (34 Act) Size: KB |
Apr-26-2016 | 161590358 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001144204-16-095418 ( Act) Size: KB |
Apr-21-2016 |
Recent 20 filings. View all China Nepstar Chain Drugstore Ltd. filings
young lad who new his job ansered questions and new what was best for me.
It's being easier working on the website. And I recommend, it's a great website
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by